Description
Adakveo (crizanlizumab) is a prescription biologic medication manufactured by Novartis Pharmaceuticals Corporation. It acts as a P-selectin blocker to help manage certain conditions. Administered intravenously as an injection at 10 mg/mL strength. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the FDA dataset for Crizanlizumab — ANDA 761128 submitted by Mylan Institutional LLC
|
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761128 |
Tags
- fda
- drug-safety
- health-care
- prescription-drugs
- medications